首页> 外文期刊>Research in Veterinary Science >Evaluation of the immune response to Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein
【24h】

Evaluation of the immune response to Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein

机译:使用HSV-1扩增子载体系统或重组蛋白评估对边缘无浆膜MSP5蛋白的免疫应答

获取原文
获取原文并翻译 | 示例
           

摘要

Anaplasma marginale is an intraerythrocytic vector-borne infectious agent of cattle. Immunization with the current vaccine, based on parasitized erythrocytes with live Anaplasma centrale, shows some constraints and confers partial protection, suggesting the feasibility for the development of new generation of vaccines. The aim of the present study was to assess the effect of sequential immunization of BALB/c mice, with herpesvirus amplicon vector-based vaccines combined with protein-based vaccines, on the quality of the immune response against the major surface protein 5 of A. marginale. The highest antibody titers against MSP5 were elicited in mice that received two doses of adjuvanted recombinant protein (p 0.0001). Mice treated with a heterologous prime-boost strategy generated sustained antibody titers at least up to 200 days, and a higher specific cellular response. The results presented here showed that sequential immunization with HSV-based vectors and purified antigen enhances the quality of the immune response against A. marginale. (C) 2014 Elsevier Ltd. All rights reserved.
机译:边缘无浆膜是牛的红细胞内载体传播的传染原。目前的疫苗的免疫是基于寄生的红细胞和活的中央无形体进行的,显示出一定的局限性并提供了部分保护,这表明开发新一代疫苗的可行性。本研究的目的是评估以疱疹病毒扩增子载体为基础的疫苗与蛋白疫苗为基础的BALB / c小鼠的顺序免疫对针对A主要表面蛋白5的免疫反应质量的影响。保证金。在接受两次剂量的佐剂重组蛋白的小鼠中,产生了针对MSP5的最高抗体滴度(p <0.0001)。用异源初免-加强策略治疗的小鼠至少持续200天产生持续的抗体滴度,并产生更高的特异性细胞反应。此处显示的结果表明,使用基于HSV的载体和纯化的抗原进行的顺序免疫可提高针对边缘拟南芥的免疫反应的质量。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号